STIM Stock Analysis: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$2.16
0.18 (9.09%)
▲
5d:
+19.34%
30d:
+53.19%
90d:
+6.93%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: STIM is 11.3% above its trading range ($1.94). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: STIM is 11.3% above its trading range ($1.94). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $2.16, which is considered extended relative to its 30-day fair value range of $1.46 to $1.94.
Technical Outlook: Technically, STIM is in a uptrend. The price is approaching resistance at $2.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.1% recently.
Market Sentiment: STIM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+127.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STIM is in a uptrend. The price is approaching resistance at $2.21. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.1% recently.
Market Sentiment: STIM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.50 (+127.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.46 -
$1.94
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.1%)
- BULLISH: Trading 127.3% below Wall St target ($4.50)
Trading Range Analysis
30-Day Trading Range
$1.46 -
$1.94
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.21
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.87
Wall Street Target
$4.50
(+127.3%)
Revenue Growth (YoY)
7.8%
Profit Margin
-24.5%
Share & Embed Analysis
Last updated: August 04, 2026 9:07 AM ET
Data refreshes hourly during market hours. Next update: 10:07 AM
Data refreshes hourly during market hours. Next update: 10:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorey Chernett
BUY
100000 shares
2026-04-20
Jorey Chernett
BUY
169472 shares
2026-03-20
Jorey Chernett
BUY
450000 shares
2026-03-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 54 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 60 HOLD |
